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Abstract
Background: Many countries are facing overlapping epidemics of tuberculosis (TB) and diabetes mellitus (DM).
Diabetes increases the overall risk of developing Tuberculosis (TB) and contributes to adverse treatment outcomes.
Active screening for both diseases can reduce TB transmission and prevent the development of complications of
DM. We investigated bi-directional TB-DM screening in Karachi, Pakistan, a country that ranks fifth among high TB
burden countries, and has the seventh highest country burden for DM.
Methods: Between February to November 2014, community-based screeners identified presumptive TB and DM
through verbal screening at private health clinics. Individuals with presumptive TB were referred for a chest X-ray
and Xpert MTB/RIF. Presumptive DM cases had random blood glucose (RBS) tested. All individuals with bacteriologically
positive TB were referred for diabetes testing (RBS). All pre-diabetics and diabetics were referred for a chest X-ray and
Xpert MTB/RIF test. The primary outcomes of this study were uptake of TB and DM testing.
Results: A total of 450,385 individuals were screened, of whom 18,109 had presumptive DM and 90,137 had presumptive
TB. 14,550 of these individuals were presumptive for both DM and TB. The uptake of DM testing among those
with presumptive diabetes was 26.1% while the uptake of TB testing among presumptive TB cases was 5.9%.
Despite efforts to promote bi-directional screening of TB and DM, the uptake of TB testing among pre-diabetes
and diabetes cases was only 4.7%, while the uptake of DM testing among MTB positive cases was 21.8%.
Conclusion: While a high yield for TB was identified among pre-diabetics and diabetics along with a high yield
of DM among individuals diagnosed with TB, there was a low uptake of TB testing amongst presumptive TB patients
who were recorded as pre-diabetic or diabetic. Bi-directional screening for TB and DM which includes the integration
of TB diagnostics, DM screening and TB-DM treatment within existing health care programs will need to address the
operational challenges identified before implementing this as a strategy in public health programs.
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Background
Nearly one third of the world’s population is infected with
Mycobacterium tuberculosis (Mtb) [1]. A growing body of
literature has established the association between tubercu-
losis (TB) and diabetes mellitus (DM) in various settings
[2]. DM increases the overall risk of developing TB and
contributes to adverse TB treatment outcomes such as de-
layed sputum conversion, treatment failure and relapse
and death [2]. The global burden of diabetes is on the rise
with the total number of people living with DM estimated
to reach 438 million by 2030 [3]. The convergence of
these two epidemics poses a significant challenge for
health systems in low and middle-income countries. Stud-
ies in India and China found significant evidence for co-
morbidity at various health care levels including tertiary
care facilities and primary healthcare clinics [4, 5]. These
studies led to important policy formulations that have
mandated screening for DM among all TB patients and
documentation of DM indicators within registries of the
TB control program in these countries.
Screening, early-case detection and prompt treatment ini-
tiation is of relevance for both diseases. In 2009, the World
Health Organization (WHO) and the International Union
Against Tuberculosis and Lung Disease (IUATLD) recom-
mended bi-directional TB-DM screening and integrated
management for both diseases in high burden countries [6].
However, in low and middle-income countries, health
systems are often weak and highly fragmented, including
large and often poorly regulated private-sectors, and are
not equipped to respond effectively to the dual burden of
communicable and non-communicable diseases [7].
Pakistan is currently ranked fifth among high TB burden
countries [1]. Nearly half of all cases remain undiagnosed
and improving case-detection is an important target for
the National TB Control Program (NTP) [1]. Pakistan also
faces a rising burden of non-communicable diseases
(NCDs), particularly Type II DM. It has the seventh high-
est country-burden for DM with an estimated prevalence
of 6.8% in the adult population [8, 9]. Similar to TB pa-
tients, diabetics are frequently under-diagnosed and an es-
timated 3.5 million adults in Pakistan are thought to be
living with undiagnosed DM [9]. In Pakistan, TB control
activities are under the purview of the National Tubercu-
losis Program (NTP), but routine screening for NCDs in-
cluding DM is not currently recommended. Interventions
also need to consider the private-sector that provides
healthcare services to nearly three-quarters of all patients
in the country [10].
In recent years, novel case-finding approaches for TB in
the private-sector have been developed to enhance
case-notifications through community-based screening,
cash-incentives for referrals and linking case-notifications
to the NTP disease surveillance system [11, 12]. Similar
public-private models with a focus on integrated care can
lower costs and improve health outcomes by shifting
diseases-specific interventions to holistic, patient-centric
approaches [13]. We investigated the feasibility of a bidir-
ectional TB and DM screening program in the private
health sector in Karachi, Pakistan as part of an enhanced
case-finding intervention for TB through a social business
approach (described below). The initiative builds upon
previous interventions carried out in the area that were
limited to targeting community-based screening for TB.
Methods
Study design and setting
A cross-sectional study of a bi-directional TB-DM screen-
ing program was conducted within a larger study investigat-
ing enhanced case-finding intervention for TB in the towns
of Korangi, Landhi, Orangi, North Karachi and Nazimabad
in Karachi, Pakistan, between February to November 2014.
Community health workers (CHW) screened patients
attending 80 general primary care, health provider clinics
for TB and DM. The screening was based on a convenience
consecutive sample. These clinics were primarily privately-
owned facilities of individual physicians and a small num-
ber of physician private group-practices, serving 50 or more
patients on average per day.
Screening and testing procedures
CHWs were trained on TB screening and treatment ac-
cording to NTP guidelines, and on DM screening accord-
ing to the International Diabetes Federation (IDF) [14].
CHWs were subsequently assigned to private health pro-
viders’ clinics where they verbally screened attendees for
presumptive TB and DM. CHWs and health care providers
were incentivized for referrals and case-detection. Presump-
tive TB was defined as cough of any duration, fever, unex-
plained weight-loss, night-sweats or hemoptysis. Patients
with presumptive DM were defined as those aged over 30
years and with a family history of DM.
TB testing was carried out at purpose-built diagnostic
centers called Sehatmand Zindagi (Healthy Life) located in
Korangi and Nazimabad. The centers operate as a social
business that aim to provide sustainable TB care in the
private-sector. Revenue is generated through direct pay-
ment for tests by patients, including chest X-rays (USD 3–
5 per test), spirometry (USD 2.5–5 per test) and random
blood glucose testing (USD 0.3–0.5 per test). Xpert MTB/
RIF testing was provided free-of-cost to all patients follow-
ing a chest X-ray. The centers served as the site of treat-
ment initiation and case-registration to the Provincial TB
Program (PTP). The revenue generated is channeled into
subsidizing TB diagnosis and treatment.
Individuals with presumptive TB were referred by the
private health provider to the social business TB centers
for a paid chest X-ray, followed by a free Xpert MTB/
RIF test. Patients with bacteriologically positive TB were
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tested for DM through a glucometer-based random
blood sugar test (RBS) at the diagnostic centers. Individ-
uals who came to the Centers with a previous diagnosis
of TB or DM were re-tested using Sehatmand Zindagi
Centers’ Chest X-ray, Xpert MTB/RIF and glucometer-
based random blood sugar tests to ensure reliable base-
line measures for diagnosis rather than depending on
external reports. 1180 individuals with known diabetes
(Table 1), defined as all those who self-reported to be
taking oral hypoglycemic medication, underwent gluc-
ometer based random blood sugar testing and then were
channeled into the presumptive DM-TB arm (Fig. 1).
Baseline data for previously diagnosed and newly diag-
nosed diabetes cases is indicated in Table 1. Previously di-
agnosed cases of diabetes were further classified as having
controlled or uncontrolled diabetes. For the purpose of
this analysis, uncontrolled diabetes was defined as RBS of
greater than 200mg/dl on glucometer testing. Those with
presumptive DM were offered a paid (US $2),
point-of-care capillary blood-glucose test that was con-
ducted by CHWs at the clinics. Cutoffs recommended by
the International Diabetes Federation for resource-limited
settings were used to categorize the patients as having
DM (≥200mg/dL (11.1mmol/L)), Pre-DM (140–199mg/
dL (7.8–11.0mmol/L)) or no diabetes (< 140mg/dL (7.8
mmol/L)). Individuals with both presumptive TB and DM,
were assigned to another diagnostic arm where the private
health provider referred patients for both tests: a point of
care glucometer test for DM and Chest X-ray and Xpert
MTB/RIF testing at the diagnostic centers.
Data management and analysis
Data on DM and TB verbal screening results, referrals,
and DM test results was recorded using a custom-built
Table 1 Baseline characteristics of patients identified as pre-diabetics and diabetics through community-based screening
Characteristics Cases diagnosed
with Pre-diabetes
Newly diagnosed
cases of Diabetes
Previously known cases of Diabetes Total
Uncontrolled Controlled
n % n % n % n % n %
Total Number of patients 726 100 547 100 901 100 279 100 2453 100
Sex
Male 334 46 236 43.1 359 39.8 100 35.8 1029 41.9
Female 392 54 311 56.9 542 60.2 179 64.2 1424 58.1
Age
< 30 74 10.2 29 5.3 28 3.1 28 10 159 6.5
30–39 195 26.9 98 17.9 129 14.3 51 18.3 473 19.2
40–49 221 30.4 176 32.2 284 31.5 58 20.8 739 30.2
50–59 135 18.6 151 27.6 284 31.5 87 31.2 657 26.8
60–69 72 9.9 68 12.4 140 15.6 32 11.5 312 12.8
> 70 29 4.0 25 4.6 36 4.0 23 8.2 113 4.5
Family History of Diabetes
Yes 265 36.5 199 36.4 402 44.6 107 38.4 994 40.5
No 461 63.5 348 63.6 499 55.4 172 61.6 1459 59.5
Current or Previous Smoking History
Yes 88 12.1 55 10.1 32 3.6 37 13.3 212 8.6
No 638 87.9 492 89.9 869 96.4 242 86.7 2241 91.4
Ethnicity
Sindhi 29 4.0 9 1.6 15 1.7 9 3.2 62 2.5
Balochi 09 1.2 5 0.9 8 0.9 4 1.4 26 1.1
Punjabi 21 2.9 18 3.3 25 2.8 20 7.2 84 3.4
Pathan 127 17.5 89 16.3 96 10.7 111 39.8 423 17.2
Muhajir 518 71.3 367 67.1 734 81.5 110 39.4 1729 70.5
Other 22 3.0 59 10.8 23 2.6 25 9.0 129 5.3
History of Hypertension
Yes 210 28.9 75 13.7 273 30.3 171 61.3 728 29.7
No 516 71.1 472 86.3 628 69.7 109 38.7 1725 70.3
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mobile-phone application. Other variables ascertained at
baseline included family-history of diabetes, smoking
history, ethnicity, and past history of TB treatment
(Table 2). Patients’ chest X-ray and Xpert MTB/RIF re-
sults at the diagnostic centers were recorded using
OpenMRS, an Open source enterprise electronic med-
ical record system platform. The mobile and web appli-
cations included several data validation checks to ensure
data-accuracy. Field supervisors and project manage-
ment staff were responsible for overall data-validation
and accuracy including reporting to the NTP.
Frequency analysis of baseline demographic character-
istics of patients diagnosed with DM and Pre-DM/Im-
paired Fasting and TB were performed. The proportions
of individuals diagnosed with Pre-DM and DM that had
TB symptoms and subsequently underwent Xpert MTB/
RIF testing and diagnosed with TB were calculated. The
proportion of newly diagnosed DM cases among TB
patients was calculated. Differences between the DM
and Pre-DM groups were assessed for statistical signifi-
cance using chi-square or Pearson’s test (Table 2). All
statistical analysis was carried out using Stata 12.1 (Col-
lege Station, TX: StataCorp LP).
The primary study outcomes were uptake of TB test-
ing and uptake of DM testing. Overall uptake of TB test-
ing, overall uptake of DM testing, uptake of TB testing
and uptake of DM testing among patients presumptive
for both DM & TB were computed (Fig. 1). Additionally,
uptake of TB testing among pre-diabetic and diabetic
patients was assessed by comparing the proportion of
pre-diabetic and diabetic individuals that underwent
Chest X-ray and Xpert MTB/RIF testing to the propor-
tion within each arm who were presumptive for TB. Up-
take of DM testing among MTB positive patients was
computed by comparing the proportion of MTB positive
patients who underwent a glucometer-based random
Fig. 1 Diagnostic algorithm and results of TB-DM bidirectional screening Feb-Nov, 2014, Karachi, Pakistan
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blood sugar test to the proportion within that arm who
were presumptive for DM. The yield of TB among indi-
viduals identified with Pre-DM and DM was computed
as the proportion of individuals who tested positive for
TB among all individuals with DM and pre-DM who
underwent TB testing via chest X-ray and Xpert MTB/
RIF in this project. The yield of DM among individuals
diagnosed with TB was calculated as the proportion of
individuals identified with DM and Pre-DM among all
individuals with TB who underwent glucometer-based
RBS testing in this project.
Results
A total of 450,385 individuals were verbally screened
during the study period. Of those verbally screened,
3559 (0.8%) were identified as having presumptive DM,
14,550 (3.2%) with both presumptive DM and TB, and
75,587 (16.8%) as having presumptive TB only (Fig. 1).
The overall uptake of DM testing among those identified
with presumptive diabetes was 26.1% while the overall
uptake of TB testing among those with presumptive TB
was 5.9% (Fig. 1). Individuals with a presumptive diagno-
sis of both DM and TB were referred for both a
Table 2 Baseline characteristics and results of glucometer testing conducted on TB patients through community-based TB-DM
screening
Persons with TB Tested for DM* Pre-Diabetes* Newly Diagnosed DM cases p-value†
n % n % n %
Total 266 100 25 100 8 100
Sex
Male 108 40.6 13 48.0 4 50.0 0.99
Female 158 59.4 12 48.0 4 50.0
Age (years)
< 20 60 22.6 4 16.0 0 0.0 < 0.01
20–29 93 35.0 5 20.0 0 0.0
30–39 43 16.2 2 8.0 1 12.5
40 and above 67 25.2 14 56.0 7 87.5
Family History of DM*
Yes 32 12.0 1 4.0 3 37.5 0.97
No 234 88.0 24 96.0 5 62.5
Current or Previous Smoking History
Yes 21 7.9 7 28.0 2 25.0 < 0.01
No 245 92.1 18 72.0 6 75.0
Ethnicity
Sindhi 14 5.3 2 8.0 2 25.0 0.11
Balochi 2 0.8 0 0.0 0 0.0
Punjabi 8 3.0 1 4.0 0 0.0
Pathan 118 44.4 5 20.0 3 37.5
Muhajir 91 34.2 12 48.0 1 12.5
Other 33 12.4 3 12.0 1 12.5
MTB Burden
Negative (clinically diagnosed) 28 10.5 3 12.0 2 25.0 0.85
Very low-low 90 33.8 9 34.0 2 25.0
Medium 90 33.8 9 36.0 3 37.5
High 58 21.8 4 16.0 1 12.5
Type of TB
New 229 86.1 22 88.0 7 87.5 0.75
Retreatment 37 13.9 3 12.0 1 12.5
*The cut-offs for RBS testing were taken from the International Diabetes federation
† The p-value denotes the level of significance found when testing differences in sociodemographic characteristics between individuals identified as new DM
cases and those identified as pre-DM, among all TB patients who had a glucometer blood sugar test
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glucometer based random blood sugar test and a Chest
X-ray and Xpert MTB/RIF test. Among the group that
was presumptive for both DM and TB, the uptake of
DM testing was 12.5% and the uptake of TB testing was
24.2% (Fig. 1).
Baseline socio-demographic and clinical characteristics of
pre-diabetic and diabetic patients
The majority of pre-diabetic and diabetic patients
self-identified as Muhajir (the most common ethnic
group in Karachi). Of those patients who tested positive
for diabetes, 547 (31.6%) were newly diagnosed. Of the
1180 previously known diabetes cases, 901 (76.4%) had
blood sugar levels above the recommended range for op-
timal diabetics control (Table 1). A higher proportion of
females were identified with pre-diabetes and diabetes
(58.1%) and a family history of diabetes, history of smok-
ing and history of hypertension was reported in 40.5, 8.6
and 29.7% of diabetics respectively. A history of hyper-
tension was reported in a higher proportion of previ-
ously known diabetics with controlled blood sugar levels
(61.3%) compared to known diabetics with poorly con-
trolled blood sugar levels (30.3%), newly diagnosed dia-
betics (13.7%) and pre-diabetics (28.9%) (Table 1).
Baseline socio-demographic characteristics of TB patients
The yield of diabetes among TB patients was found to
be significantly higher in patients > 40 years of age
(p-value < 0.01) and among smokers compared to
non-smokers (p-value < 0.01) (Table 2). Gender, MTB
burden, ethnicity and past history of TB treatment were
not associated with an increased yield of DM (Table 2).
Uptake of diabetes testing
A total of 4722 (26.1%) individuals with presumptive
DM underwent glucometer testing, with 726 (15.4%)
identified as pre-diabetic (198 of whom had both pre-
sumptive TB and DM), and 1727 (36.6%) diagnosed with
diabetes (432 of whom had both presumptive DM and
TB). Among those diagnosed with TB, a higher propor-
tion of those with presumptive DM consented for DM
screening using a glucometer, than those without pre-
sumptive DM (33.8% vs 14.7%, p < 0.001). Among those
who underwent glucometer testing, 25 (9.4%) were iden-
tified as pre-diabetics and 8 (3%) as diabetics. Of those
diagnosed with diabetes and pre-diabetes, 100 and 56%
(14/25) had presumptively screened positive for DM
(Fig. 1). The median age of individuals identified as pre-
sumptive for TB and DM was 34 years (IQR 25–45), and
47 years (IQR 38–55) respectively. The proportion of fe-
males among those identified as presumptive for TB and
DM, was 47.4 and 50.1% respectively.
Uptake of TB testing
A high proportion (22.8%) of individuals with presumptive
TB, tested positive for MTB on Xpert MTB/RIF. Overall,
the uptake of screening for tuberculosis was quite low
among prediabetics and diabetics. 6.6% of prediabetic
cases and 3.9% of diabetic cases underwent TB testing via
Chest X-ray and Xpert MTB/RIF. However, the uptake
was significantly higher among those who had presump-
tive TB (22.2% vs 0.8% among pre-diabetics; and 13.7% vs
0.62% among diabetics). Of the 153 who consented for TB
testing, 153 had a chest X-ray and among these 115
(75.2%) underwent Xpert MTB/RIF testing (the remainder
were unable to expectorate sputum and excluded from
further diagnostic evaluation) (Table 3). A total of 8
pre-diabetics (16.7%) and 19 diabetics (28.4%) tested posi-
tive for TB on Xpert MTB/RIF testing (Fig. 1).
Discussion
Our study evaluated bi-directional TB-DM screening in
a high TB and DM prevalence setting. In this study, the
yield of TB among those with diabetes and pre-diabetes
was 23.5% while the yield of pre-DM/DM among indi-
viduals who had tested positive for TB was 12.4% (Fig.
1). However, it is important to note that the yield of TB
in our sample has a great risk of selection bias. Notably
all had presumptive TB; the number of diabetics without
presumptive TB who took up screening was too small to
comment on the yield of TB among those tested for TB
without any suggestive symptoms. A number of studies,
as well as the Pakistan TB prevalence survey have identi-
fied a large proportion of TB cases with only Chest
X-ray abnormalities and no TB symptoms supporting its
use as the front-line screening procedure [15]. There-
fore, we aimed to test all individuals for TB using chest
radiography, regardless of symptoms. In circumstances
where chest X-rays are unavailable symptomatic screen-
ing can be used as an alternative. In this study, a high
yield of TB was recorded among those with TB symp-
toms. We were unable to assess the effectiveness of the
chest X-ray in identifying additional cases of TB as the
majority of cases referred were also symptomatic for TB.
While our study supports the growing body of litera-
ture highlighting the association between TB and DM
[8] it primarily identifies a number of operational con-
straints that programs may need to address during larger
scale TB-DM screening interventions. A high yield of
TB was found among the diabetics and pre-diabetics
within our study population. The uptake of diagnostic
evaluation for TB was low, and mainly confined to those
who had symptoms suggestive of TB. In addition, since
physician prescriptive practices also significantly affect
patient behavior, it is possible that only diabetics with
clinical suspicion of TB were actively referred [16]. Add-
itional constraints in testing diabetics for TB included
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the price for the chest X-ray and the distance to the cen-
ters for diagnostic evaluation. Our experience suggests
that in a pay for testing model only diabetics with a high
suspicion of TB will be referred, as both providers and
patients perceived the costs and time associated with the
X-ray as key barriers. Also, approximately a quarter of
patients who agreed to undergo a chest X-ray, could not
be tested on Xpert MTB/RIF due to their inability to ex-
pectorate sputum and this further limited the number of
diabetics among whom the yield of TB could be assessed.
Our early experience of implementing TB-DM screen-
ing in a programmatic setting in the private-sector offers
a number of lessons for potential interventions that can
be carried out at scale. Firstly, physicians must be
trained to refer diabetics for routine screening for TB, as
is carried out for other diabetes-associated complications
such as nephropathy or retinopathy. Patients also need
to be appropriately counseled regarding the risks of de-
veloping TB, particularly those with poorly controlled
diabetes since they are at higher risk for developing TB
[17]. Secondly, user-fees for the X-ray and distance to
the TB centers limited the number of diabetics undergo-
ing TB screening in our program. It can be assumed that
user fee is likely a barrier to uptake of preventive health
services such as screening for TB and DM. As a pre-
ventative intervention with potential public health bene-
fits, cost-free or subsidized services may increase uptake
of TB testing. This may likely encourage pre-diabetics
and diabetics to undergo screening, particularly those
who have no symptoms of TB, and will help decrease
the case-detection gap for TB. Public health practi-
tioners and program managers that are eager to roll out
a bi-directional TB-DM screening program in the private
sector, should incorporate greater cost subsidies for pa-
tients in the program budget. Third, scale-up of TB
screening in diabetics will require ensuring adequate
sputum expectoration from diabetics through use of
nebulizers and appropriate counseling. Commercial labs
in the private-sector and most healthcare providers do
not routinely carry out such procedures and will require
capacity-strengthening. Existing specialized diabetes
treatment centers with high volumes of known diabetics
or private-practices of diabetes and endocrine specialists
can be targeted to refer diabetics for TB screening.
Over 50% of diabetics and pre-diabetics identified in
our program were newly diagnosed further highlighting
the burden of undiagnosed diabetes and the need to
introduce affordable and accessible diabetes screening in
the private-sector at scale as a prelude for enhanced
case-detection for TB.
Screening for DM among TB patients presented fewer
operational challenges in our model as patients were of-
fered screening during the time of registration for TB
treatment. The yield of pre-DM and DM identified
among individuals with TB in our program was higher
(12.4%) than the DM prevalence in the general popula-
tion of Pakistan (6.9%) [8]. This is consistent with find-
ings from similar studies from India that have reported a
prevalence between 5 and 54.1% of DM in TB patients
[18–20]. Routine screening for DM among TB patients
should therefore be considered at TB management facil-
ities in Pakistan.
Diabetes screening for TB patients can be best carried
out at the time of initiation of TB treatment and registra-
tion. Low-cost, point-of-care tests for diabetes are recom-
mended as patients are more likely to consent to them
although their results are less accurate. Interventions will
need to ensure that these tests are available either at labora-
tories or at provider clinics where TB treatment is initiated
for private-sector patients and data on diabetes screening
and control is captured as part of the TB surveillance sys-
tem. Integrated delivery units such as the ones developed
by our project offer a potential solution where TB diagnos-
tics, DM screening and TB-DM treatment can be offered
in one facility with supporting systems for data capture and
monitoring of outcomes.
Conclusion
This study provides evidence for the operationalization
and the associated challenges of bi-directional screening
of TB and DM in the private health sector of low-middle
income countries. A high yield for TB was identified
among diabetics and pre-diabetics in our study popula-
tion, however the overall uptake of bi-directional screen-
ing remained low. A large number of diabetics were newly
identified suggesting the need for implementation of col-
lateral active case-finding initiatives for DM. This study
also provides a potential model for integration of TB
Table 3 Xpert MTB/RIF test results of individuals diagnosed with Diabetes and Pre-Diabetes through community-based screening
Individuals identified with Pre-Diabetes Individuals identified with Diabetes Mellitus Total
Number(n) Percent (%) Number (n) Percent (%) Number (n) Percent (%)
Total 726 100 1727 100 2453 100
Underwent Paid Chest X-Ray 62 8.5 91 5.3 153 6.2
Underwent Xpert MTB/RIF 48 77.4 67 73.6 115 75.2
Diagnosed with TB 8 16.7 19 28.4 27 23.5
Started on treatment for TB 8 100 19 100 27 100
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diagnostics, DM screening and TB-DM treatment within
one facility that can be similarly adapted for other areas of
public health. The private sector can be engaged
cost-effectively through trainings and incentives to help
achieve increased case-detection for both TB and DM.
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